Myocardial Cell Signaling During the Transition to Heart Failure
Authors:
- 1 January 2019
- journal article
- Published by Wiley in Comprehensive Physiology
- Vol. 9 (1) , 75-125
Abstract
Cardiovascular disease leading to heart failure (HF) remains a leading cause of morbidity and mortality worldwide. Improved pharmacological and interventional coronary procedures have led to improved outcomes following acute myocardial infarction. This success has translated into an unforeseen increased incidence in HF. This review summarizes the signaling pathways implicated in the transition to HF following cardiac injury. In addition, we provide an update on cell death signaling and discuss recent advances in cardiac fibrosis as an independent event leading to HF. Finally, we discuss cell‐based therapies and their possible use to avert the deteriorating nature of HF. © 2019 American Physiological Society. Compr Physiol 9:75‐125, 2019.Keywords
This publication has 574 references indexed in Scilit:
- Textile Technologies and Tissue Engineering: A Path Toward Organ WeavingAdvanced Healthcare Materials, 2016
- Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic CardiomyopathyJAMA, 2014
- 25th Anniversary Article: Rational Design and Applications of Hydrogels in Regenerative MedicineAdvanced Materials, 2013
- Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac TissueAdvanced Functional Materials, 2013
- Lifetime Risk and Years Lived Free of Total Cardiovascular DiseaseJAMA, 2012
- Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart FailureJAMA, 2012
- Hyaluronic Acid Hydrogels for Biomedical ApplicationsAdvanced Materials, 2011
- Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged AdultsJAMA, 2004
- Current Smoking, Smoking Cessation, and the Risk of Sudden Cardiac Death in Patients With Coronary Artery DiseaseArchives of internal medicine (1960), 2003
- Cloning and characterization of the murine homolog of thesno proto-oncogene reveals a novel splice variantDevelopmental Dynamics, 1996